机译:淋巴瘤患者中的化疗和随后放射治疗的心脏影响是什么?
Department of Translational Medical Sciences Federico II University;
Department of Translational Medical Sciences Federico II University;
Department of Medicine and Surgery Federico II University;
Department of Translational Medical Sciences Federico II University;
Institute of Biostructures and Bioimaging National Research Council (CNR);
Department of Translational Medical Sciences Federico II University;
Department of Translational Medical Sciences Federico II University;
Department of Translational Medical Sciences Federico II University;
Department of Translational Medical Sciences Federico II University;
Department of Translational Medical Sciences Federico II University;
Department of Translational Medical Sciences Federico II University;
Department of Translational Medical Sciences Federico II University;
Department of Translational Medical Sciences Federico II University;
Department of Translational Medical Sciences Federico II University;
Department of Advanced Biomedical Sciences Federico II University;
Department of Advanced Biomedical Sciences Federico II University;
Department of Translational Medical Sciences Federico II University;
anthracycline cardiotoxicity; cardiac damage from radiotherapy; oxidative damage; echocardiography; adult lymphoma;
机译:淋巴瘤患者中的化疗和随后放射治疗的心脏影响是什么?
机译:诱导化疗对后续放疗剂量参数的影响:对30例局部晚期非小细胞肺癌连续患者的调查和现代放射计划技术
机译:诱导化疗对后续放疗剂量参数的影响:对30例局部晚期非小细胞肺癌连续患者的调查和现代放射计划技术
机译:化疗后犬B细胞淋巴瘤的延长缓解和存活和低剂量率半体放射治疗
机译:弥漫性大B细胞淋巴瘤化疗后患者生存的预后生物标志物:88例回顾性分析
机译:诱导化疗对后续放疗剂量参数的影响:对30例局部晚期非小细胞肺癌连续患者和现代放射计划技术的调查
机译:系统性化学疗法和放射疗法治疗原发性心脏淋巴瘤患者的长期无病生存